Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 10412 | 1000 | 47.7 | 93% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | GATA 1 | Author keyword | 23 | 25% | 8% | 77 |
| 2 | GATA 2 | Author keyword | 14 | 42% | 3% | 27 |
| 3 | EDAG | Author keyword | 13 | 80% | 1% | 8 |
| 4 | GATA 6 | Author keyword | 12 | 45% | 2% | 20 |
| 5 | GATA2 | Author keyword | 10 | 35% | 2% | 24 |
| 6 | GATA 4 | Author keyword | 9 | 29% | 3% | 28 |
| 7 | GATA | Author keyword | 8 | 18% | 4% | 37 |
| 8 | DEV DIFFERENCIAT CARDIAQ | Address | 6 | 80% | 0% | 4 |
| 9 | MONOMAC | Author keyword | 5 | 63% | 1% | 5 |
| 10 | CELL REGENERAT BIOL MED PUBL HLTH | Address | 4 | 75% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | GATA 1 | 23 | 25% | 8% | 77 | Search GATA+1 | Search GATA+1 |
| 2 | GATA 2 | 14 | 42% | 3% | 27 | Search GATA+2 | Search GATA+2 |
| 3 | EDAG | 13 | 80% | 1% | 8 | Search EDAG | Search EDAG |
| 4 | GATA 6 | 12 | 45% | 2% | 20 | Search GATA+6 | Search GATA+6 |
| 5 | GATA2 | 10 | 35% | 2% | 24 | Search GATA2 | Search GATA2 |
| 6 | GATA 4 | 9 | 29% | 3% | 28 | Search GATA+4 | Search GATA+4 |
| 7 | GATA | 8 | 18% | 4% | 37 | Search GATA | Search GATA |
| 8 | MONOMAC | 5 | 63% | 1% | 5 | Search MONOMAC | Search MONOMAC |
| 9 | HEMOGEN | 4 | 75% | 0% | 3 | Search HEMOGEN | Search HEMOGEN |
| 10 | GATA FACTOR | 4 | 23% | 2% | 15 | Search GATA+FACTOR | Search GATA+FACTOR |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRANSCRIPTION FACTOR GATA 1 | 105 | 33% | 27% | 266 |
| 2 | HEART TUBE FORMATION | 33 | 30% | 9% | 91 |
| 3 | TRANSCRIPTION FACTOR GATA 2 | 22 | 38% | 5% | 47 |
| 4 | MONOMAC SYNDROME | 22 | 62% | 2% | 23 |
| 5 | SPORADIC MONOCYTOPENIA | 21 | 61% | 2% | 23 |
| 6 | VENTRAL MORPHOGENESIS | 21 | 22% | 8% | 82 |
| 7 | EMBERGER SYNDROME | 18 | 89% | 1% | 8 |
| 8 | TRANSCRIPTION FACTOR GATA 4 | 15 | 28% | 5% | 45 |
| 9 | CHROMATIN OCCUPANCY | 14 | 36% | 3% | 32 |
| 10 | MEGAKARYOCYTIC DIFFERENTIATION | 14 | 21% | 6% | 60 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| GATA Switches as Developmental Drivers | 2010 | 67 | 97 | 71% |
| The zinc finger-containing transcription factors GATA-4,-5, and-6 - Ubiquitously expressed regulators of tissue-specific gene expression | 2000 | 493 | 87 | 63% |
| GATA2 deficiency | 2015 | 1 | 36 | 75% |
| GATA1 function, a paradigm for transcription factors in hematopoiesis | 2005 | 159 | 134 | 63% |
| MonoMAC Syndrome in a Patient With a GATA2 Mutation: Case Report and Review of the Literature | 2013 | 11 | 10 | 70% |
| The role of the GATA2 transcription factor in normal and malignant hematopoiesis | 2012 | 29 | 173 | 61% |
| Role of the GATA family of transcription factors in endocrine development, function, and disease | 2008 | 74 | 218 | 44% |
| Combinatorial regulation of tissue specification by GATA and FOG factors | 2012 | 23 | 137 | 64% |
| Human phenotypes associated with GATA-1 mutations | 2008 | 38 | 45 | 62% |
| GATA1 in normal and malignant hematopoiesis | 2005 | 98 | 89 | 63% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | DEV DIFFERENCIAT CARDIAQ | 6 | 80% | 0.4% | 4 |
| 2 | CELL REGENERAT BIOL MED PUBL HLTH | 4 | 75% | 0.3% | 3 |
| 3 | PROGRAM DEV REPROD BIOL | 3 | 20% | 1.5% | 15 |
| 4 | CELL REGENERAT BIOLWISCONSIN MED | 3 | 100% | 0.3% | 3 |
| 5 | UW MADISON BLOOD PROGRAM | 3 | 100% | 0.3% | 3 |
| 6 | ONTOGENY REPROD UNIT | 3 | 32% | 0.7% | 7 |
| 7 | DEV DIFFERENCIAT CARDIAQUES | 2 | 36% | 0.5% | 5 |
| 8 | MADISON BLOOD PROGRAM | 2 | 67% | 0.2% | 2 |
| 9 | MED SCI 383 | 2 | 67% | 0.2% | 2 |
| 10 | MED PATHOL PEDIAT | 2 | 25% | 0.6% | 6 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000221499 | LOCUS CONTROL REGION//HEMOGLOBIN SWITCHING//EKLF |
| 2 | 0.0000181685 | LMO4//LDB1//LMO2 |
| 3 | 0.0000156697 | PU1//SPI 1 PU1//SFPI1 PU1 |
| 4 | 0.0000111236 | ERYTHROPOIETIN RECEPTOR//STEM PROGENITOR CELL BIOL PROGRAM//ERYTHROBLAST MACROPHAGE PROTEIN |
| 5 | 0.0000104823 | GFI1B//GFI1//ZELLBIOL TUMORFOR |
| 6 | 0.0000087131 | TRANSIENT MYELOPROLIFERATIVE DISORDER//TRANSIENT LEUKEMIA//TRANSIENT ABNORMAL MYELOPOIESIS |
| 7 | 0.0000086462 | HEART DEVELOPMENT//SECOND HEART FIELD//NKX2 5 |
| 8 | 0.0000085080 | MAMMAGLOBIN//MAMMAGLOBIN A//HUMAN MAMMAGLOBIN |
| 9 | 0.0000079475 | HEMANGIOBLAST//HEMOGENIC ENDOTHELIUM//AORTA GONAD MESONEPHROS |
| 10 | 0.0000077388 | HDR SYNDROME//KENNY CAFFEY SYNDROME//HYPOPARATHYROIDISM |